Novo CEO pressed by Senate to chop costs of obesity, diabetes medication CEO Lars Fruergaard Jørgensen instructed lawmakers the business would look at new talks with insurers with regard to the record price ranges of Wegovy and copyright when they pledge to help keep the medicines on their formularies. Given https://lorenzodzupn.bloginder.com/31282549/the-5-second-trick-for-healthcare-news